Kjalke M - Search Results

1

Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.

Aljamali MN, Kjalke M, Hedner U, Ezban M, Tranholm M. Aljamali MN, et al. Among authors: kjalke m. Haemophilia. 2009 Nov;15(6):1318-26. doi: 10.1111/j.1365-2516.2009.02073.x. Epub 2009 Jul 29. Haemophilia. 2009. PMID: 19659796

2

Amino acid residues 721-729 are required for full factor VIII activity.

Kjalke M, Heding A, Talbo G, Persson E, Thomsen J, Ezban M. Kjalke M, et al. Eur J Biochem. 1995 Dec 15;234(3):773-9. doi: 10.1111/j.1432-1033.1995.773_a.x. Eur J Biochem. 1995. PMID: 8575434 Free article.

3

Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor.

Sorensen BB, Persson E, Freskgârd PO, Kjalke M, Ezban M, Williams T, Rao LV. Sorensen BB, et al. Among authors: kjalke m. J Biol Chem. 1997 May 2;272(18):11863-8. doi: 10.1074/jbc.272.18.11863. J Biol Chem. 1997. PMID: 9115245 Free article.

4

The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.

Kjalke M, Oliver JA, Monroe DM, Hoffman M, Ezban M, Hedner U, Roberts HR. Kjalke M, et al. Thromb Haemost. 1997 Oct;78(4):1202-8. Thromb Haemost. 1997. PMID: 9364985

5

Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.

Kjalke M, Monroe DM, Hoffman M, Oliver JA, Ezban M, Roberts HR. Kjalke M, et al. Thromb Haemost. 1998 Oct;80(4):578-84. Thromb Haemost. 1998. PMID: 9798973

6

The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.

Kjalke M, Monroe DM, Hoffman M, Oliver JA, Ezban M, Hedner U, Roberts HR. Kjalke M, et al. Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S21-5. Blood Coagul Fibrinolysis. 1998. PMID: 9819025 Review.

7

Plasma lipoproteins enhance tissue factor-independent factor VII activation.

Kjalke M, Silveira A, Hamsten A, Hedner U, Ezban M. Kjalke M, et al. Arterioscler Thromb Vasc Biol. 2000 Jul;20(7):1835-41. doi: 10.1161/01.atv.20.7.1835. Arterioscler Thromb Vasc Biol. 2000. PMID: 10894826

8

High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system.

Kjalke M, Ezban M, Monroe DM, Hoffman M, Roberts HR, Hedner U. Kjalke M, et al. Br J Haematol. 2001 Jul;114(1):114-20. doi: 10.1046/j.1365-2141.2001.02870.x. Br J Haematol. 2001. PMID: 11472355 Free article.

9

Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development.

Jurlander B, Thim L, Klausen NK, Persson E, Kjalke M, Rexen P, Jørgensen TB, Østergaard PB, Erhardtsen E, Bjørn SE. Jurlander B, et al. Among authors: kjalke m. Semin Thromb Hemost. 2001 Aug;27(4):373-84. doi: 10.1055/s-2001-16971. Semin Thromb Hemost. 2001. PMID: 11547359 Review.

10

Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia-like conditions in vitro.

Kjalke M, Johannessen M, Hedner U. Kjalke M, et al. Semin Hematol. 2001 Oct;38(4 Suppl 12):15-20. doi: 10.1016/s0037-1963(01)90142-8. Semin Hematol. 2001. PMID: 11735105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters